Ilika plc Q&A with CFO Steve Boydell (LON:IKA)

Ilika plc

Ilika plc (LON:IKA) Chief Financial Officer Steve Boydell caught up with DirectorsTalk for an exclusive interview to discuss their final results, the importance of China, their ‘Goliath’ programme and more details on the placing and open offer.

 

Q1: You’ve released your results this morning and we can see that revenues have doubled, indicating the increasing commercial momentum. What measures are you taking to ensure this growth is sustained?

A1: We’ve deployed a team of four business development directors globally; in the US, China, Japan and here in Europe and close management of them is expected to sustain our growth this year and beyond.

 

Q2: I note that you’ve named three Stereax development programmes which look to be an exciting indicator or commercial traction; two are for industrial applications and one for medical. Does this split reflect the broader expressions in the interest Ilika has in technology?

A2: Industrial and medical are the two most important near-term sectors for us but more than half of the evaluations of our technology are actually with medical device companies.

 

Q3: One of your programmes is with Titan Wind in China, will this be an important jurisdiction, do you think?

A3: Very much so, yes. As I mentioned before, we have a business development director in China and one of our technical directors is just about to accompany him on a tour of potential partners there.

China have a large installed asset base that can benefit from industrial automation powered by our Stereax technology. There’s also significant interest in accessing our larger format battery technology to underpin China’s 5-year plan.

 

Q3: How do you intend to protect Ilika’s IP in China?

A3: That’s a good question. By careful screening of potential partners ensuring that they have a track record in international collaborations in which they respect patents.

 

Q4: You’ve just mentioned large format batteries, and I think they’re code named ‘Goliath’, has this become important part of your road map since January?

A4: Yes, we’ve had a lot of inbound interest and we’ve recently received significant offers of support from Innovate UK and are now putting together contracts in place with project partners.

 

Q5: You also announced today that you’ve completed a placing and initiated an open offer, what can you tell us about that?

A5: So, the placing is to ensure that Ilika have sufficient funds to invest in the capital equipment required for the ‘Goliath’ programme and to provide enough working capital for our other ongoing programmes. I would encourage retail investors to watch the video we’ve made in support of the open offer and I hope that they’ll choose to support the company through this exciting period of our development.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Dr Tom McColm on Ilika: Stereax revenues and Goliath milestones (LON:IKA)

Clean-tech equities specialist Dr Tom McColm reviews Ilika’s interim results, highlighting stable cash levels, the first recurring commercial revenues from Stereax, and continued technical and manufacturing progress on the Goliath battery platform.

Ilika CEO Graeme Purdy on Stereax and Goliath progress (LON:IKA)

Graeme Purdy, CEO of Ilika, outlines progress in manufacturing readiness and early customer shipments for the Stereax miniature solid-state battery, as well as ongoing grant-supported development and customer engagement for the Goliath EV battery programme.

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications.

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Search

Search